Donor Login
Contact Us
Breakthrough T1D
About
Investment Strategy
Portfolio
Our Team
Venture Philanthropy
News
Donor Login
Get in Touch
News and Press
EGLE Therapeutics Strengthens its Board of Directors with the Appointment of Michel Detheux, Ph.D., as Independent Chairman Board Member, and with the Appointment of Mojgan Hossein-Nia, Ph.D. as Board Member Representative of Takeda Ventures
September 12, 2024 |
Paris, France
Abata Therapeutics Announces Strategic Investment from Bristol Myers Squibb Supporting Advancement of its Treg Cell Therapy Pipeline into Clinical Development
August 15, 2024
Abata Therapeutics Announces FDA Clearance of Investigational New Drug Application for Clinical Evaluation of ABA-101 in Progressive Multiple Sclerosis
July 09, 2024
FDA Provides Clearance to IND Application for Type 1 Diabetes Therapy SAB-142 by SAB Biotherapeutics
May 21, 2024
COUR Pharmaceuticals Appoints Paul M. Peloso, MD, as Chief Medical Officer
May 21, 2024
